Virmedex Wins the 15th Research Valuation Award from the UPC Social Council
The award recognizes the successful technology transfer born in the research laboratories of the TecSalut group.
Barcelona, Spain //
The Social Council of the Universitat Politècnica de Catalunya (UPC) has awarded Virmedex first prize in the 15th edition of the Research Valuation Awards under the “Best Technology-Based Company” category.
The jury highlighted Virmedex’s achievement in translating over twenty years of academic research from the TecSalut group into a highly scalable, SaaS business model with an active commercial presence in competitive international markets, including the United States. Read more (Spanish)
More news
Virmedex: When Video Games Save Lives in the Operating Room
Specialist portal Aware.Doctor analyzes Virmedex's brand identity, 3D design language, and its educational philosophy of building resilience through controlled mistakes in virtual environments.
Read the article →
Virmedex Awarded the City of Barcelona Prize for Applied Innovation
Academic and public media celebrate Virmedex receiving the City of Barcelona Prize for its outstanding achievements in applied technological innovation within the healthcare sector.
Read the article →
Rapid adoption across United States medical programs validates the cloud educational model, paving the way for a Series A round.
Virmedex announces the growth of its software subscriptions in European hospitals and US universities, moving forward with strategic preparations to open a second funding round in mid-2026.
Read the article →